Trial Identifier: | D0816C00016 |
Sponsor: | AstraZeneca |
NCTID:: | NCT03534453 |
Start Date: | May 2018 |
Primary Completion Date: | December 2024 |
Study Completion Date: | December 2024 |
Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |
CN | Wuhan, CN, 430030 |